https://techcrunch.com/2020/05/11/biotherapeutics-startup-hummingbird-bioscience-brings-its-total-series-b-funding-to-25-million/

Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the round’s total to $25 million.

The extension was led by SK Holdings, and included participation from returning investors including Heritas Capital and SEEDS Capital, the investment arm of Enterprise Singapore, a government agency that supports small- to medium-sized businesses.